- JP-listed companies
- Sumitomo Pharma Co., Ltd.
- Income statement
Sumitomo Pharma Co., Ltd.【JP:4506】Income statement
Market cap
¥1.16T
P/E ratio
12.6x
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Revenue | 350,395 | 347,724 | 387,693 | 371,370 | 403,206 | 411,638 | 477,966 | 459,267 | 482,732 | 515,952 | 560,035 | 555,544 | 314,558 | 398,832 |
| Cost of revenue | - | - | - | 101,227 | 104,470 | 100,078 | 66,590 | 113,553 | 129,673 | 137,773 | 157,127 | 178,919 | 126,577 | 153,437 |
| Gross profit | - | - | - | 270,142 | 298,736 | 311,560 | 184,511 | 345,714 | 353,059 | 378,179 | 402,908 | 376,625 | 187,981 | 245,395 |
| Gross margin (%) | - | - | - | |||||||||||
| Operating income | - | - | - | 23,275 | 36,929 | 52,759 | 74,568 | 57,884 | 83,239 | 71,224 | 60,234 | -76,979 | -354,859 | 28,804 |
| Operating expenses | - | - | - | 246,867 | 261,805 | 258,808 | 109,943 | 180,439 | 154,348 | 190,373 | 249,081 | 373,316 | 429,538 | 180,605 |
| Income before tax | 18,872 | 24,505 | 40,631 | 23,331 | 35,221 | 54,341 | 84,866 | 65,046 | 83,947 | 77,851 | 82,961 | -47,920 | -323,114 | 17,611 |
| Provision for income taxes | - | - | - | 18,307 | 14,863 | 18,226 | 17,180 | 16,419 | 48,029 | 41,022 | 42,361 | 48,794 | -8,185 | -6,024 |
| Net income | 22,058 | 11,356 | 15,210 | 15,447 | 24,697 | 28,991 | 53,448 | 48,627 | 40,753 | 56,219 | 56,413 | -74,512 | -314,969 | 23,634 |
| Earnings per share | 21.72 | 25.28 | 50.49 | 38.88 | 62.16 | 72.97 | 134.53 | 122.39 | 102.58 | 141.5 | 141.99 | -187.55 | -792.79 | 59.49 |
| Dividend per share | 18 | 18 | 18 | 18 | 18 | 20 | 28 | 28 | 28 | 28 | 28 | 21 | - | - |